An enzyme-based treatment developed by Yale researchers mitigated autoimmunity and reduced death rates in both genetic and non-genetic mouse lupus models, a new study reveals. The findings, which were published June 18 in the journal JCI Insight, represent a significant advancement in autoimmune disease therapeutics, said the researchers. Lupus is a chronic autoimmune disease that can cause inflammation and pain in any part of the body. “Although lupus was recently recognized as among the leading causes of death in young females in the U.S., we don’t really understand what causes Read More